原发性肺癌介入治疗的现状与进展  

Progress in interventional treatment of primary lung cancer

作　　者：王瑞涛[1] 

机构地区：[1]武警后勤学院附属医院肝胆胰脾科,天津300162

出　　处：《武警后勤学院学报（医学版）》2013年第11期1049-1052,共4页Journal of Logistics University of PAP（Medical Sciences）

基　　金：国家自然科学基金(31200838);武警后勤学院创新团队基金(WHTD201310)

摘　　要：随着介入治疗技术的不断发展,针对支气管肺癌的治疗方法、方式逐渐增多,但各有利弊,具体疗效也各有不同。当前临床研究的重点和难点问题就是怎样才能够让中、晚期肺癌患者得到更合理及有效的治疗、延长生存时间、减少痛苦、改善其生存质量。因此本文针对肺癌患者临床上介入治疗的现状及进展进行综述。Abstract： With the development of interventional therapy applications for primary lung cancer,the treatment of lung cancer is gradually increased, hut the advantages and disadvantages, as well as the specific effects are different. Current clinical research on the important and difficult question are the ways to make advanced lung cancer patients being more reasonable and effective treated, to prolong-survival time, to reduce pain, and to improve their quality of life.This article reviewed the status and progress of interventional therapy for patients with lung cancer.

关 键 词：支气管肺癌 介入治疗 经支气管动脉灌注化疗 经支气管动脉栓塞术 肺动脉灌注化疗 

分 类 号：R734.2[医药卫生—肿瘤]